SINOPHARM (01099) intends to appoint Sun Jinglin as an executive director.
China National Pharmaceutical Group Corporation (01099) announced in a statement that on January 8, 2025, the board of directors has resolved to recommend the appointment of Mr. Sun Jinglin...
Sinopharm (01099) announced that on January 8, 2025, the board of directors proposed to appoint Mr. Sun Jinglin (Mr. Sun) as an executive director, and to appoint Mr. Hu Ligang (Mr. Hu), Mr. Zu Jing (Mr. Zu), and Mr. Xing Yonggang (Mr. Xing) as non-executive directors.
Due to work requirements, Mr. Wang Kan and Mr. Wang Peng resigned as non-executive directors on January 8, 2025, and their resignations took effect immediately.
Related Articles
ZHAOJIN MINING (01818): The first phase of the 2024 Mid-Term Note (Innovation Note) will pay interest on May 16th.
Jinjian Cereals Industry (600127.SH) plans to increase the capital of its wholly-owned subsidiary by 29 million yuan.
On May 9, FIRST PACIFIC (00142) issued 10,000 shares under the Caina Technology stock option plan.
ZHAOJIN MINING (01818): The first phase of the 2024 Mid-Term Note (Innovation Note) will pay interest on May 16th.
Jinjian Cereals Industry (600127.SH) plans to increase the capital of its wholly-owned subsidiary by 29 million yuan.
On May 9, FIRST PACIFIC (00142) issued 10,000 shares under the Caina Technology stock option plan.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
